Prof Chris Probert MD FRCP FHEA

Professor of Gastroenterology Cellular and Molecular Physiology

    Publications

    2020

    Commentary: vitamin D supplementation in Crohn's disease. (Journal article)

    Probert, C. (2020). Commentary: vitamin D supplementation in Crohn's disease.. Alimentary pharmacology & therapeutics, 51(1), 201-202. doi:10.1111/apt.15524

    DOI: 10.1111/apt.15524

    2019

    Macrophage-Specific NF-kappa B Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients (Journal article)

    Papoutsopoulou, S., Burkitt, M. D., Bergey, F., England, H., Hough, R., Schmidt, L., . . . Probert, C. S. (2019). Macrophage-Specific NF-kappa B Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients. FRONTIERS IN IMMUNOLOGY, 10. doi:10.3389/fimmu.2019.02168

    DOI: 10.3389/fimmu.2019.02168

    Oral Crohn's Disease: The proof is in the "cinnamon-free" pudding. (Journal article)

    Crooks, B., Probert, C. S., & Limdi, J. K. (2019). Oral Crohn's Disease: The proof is in the "cinnamon-free" pudding.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. doi:10.1016/j.cgh.2019.09.005

    DOI: 10.1016/j.cgh.2019.09.005

    DNA extraction and amplicon production strategies deeply influence the outcome of gut mycobiome studies (Journal article)

    Frau, A., Kenny, J. G., Lenzi, L., Campbell, B. J., Ijaz, U. Z., Duckworth, C. A., . . . Probert, C. S. J. (2019). DNA extraction and amplicon production strategies deeply influence the outcome of gut mycobiome studies. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-44974-x

    DOI: 10.1038/s41598-019-44974-x

    SARI attenuates colon inflammation by promoting STAT1 degradation in intestinal epithelial cells (Journal article)

    Dai, L., Liu, Y., Cheng, L., Wang, H., Lin, Y., Shi, G., . . . Deng, H. (2019). SARI attenuates colon inflammation by promoting STAT1 degradation in intestinal epithelial cells. MUCOSAL IMMUNOLOGY, 12(5), 1130-1140. doi:10.1038/s41385-019-0178-9

    DOI: 10.1038/s41385-019-0178-9

    A longitudinal study of the faecal microbiome and metabolome of periparturient mares (Journal article)

    Salem, S. E., Hough, R., Probert, C., Maddox, T. W., Antczak, P., Ketley, J. M., . . . Archer, D. C. (2019). A longitudinal study of the faecal microbiome and metabolome of periparturient mares. PEERJ, 7. doi:10.7717/peerj.6687

    DOI: 10.7717/peerj.6687

    Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply (Journal article)

    Bond, A., & Probert, C. (2019). Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 49(8), 1087-1088. doi:10.1111/apt.15196

    DOI: 10.1111/apt.15196

    Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer (Journal article)

    Bond, A., Greenwood, R., Lewis, S., Corfe, B., Sarkar, S., O'Toole, P., . . . Probert, C. (2019). Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 49(8), 1005-1012. doi:10.1111/apt.15140

    DOI: 10.1111/apt.15140

    Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis. (Journal article)

    Davis, R., McParland, P., Dodd, S., Storey, D., Probert, C., Collins, P., . . . Subramanian, S. (2019). Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis.. European journal of gastroenterology & hepatology. doi:10.1097/meg.0000000000001395

    DOI: 10.1097/meg.0000000000001395

    Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial. (Journal article)

    Thomas, M. G., Bayliss, C., Bond, S., Dowling, F., Galea, J., Jairath, V., . . . Raine, T. (2019). Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial.. BMJ open, 9(2), e023765. doi:10.1136/bmjopen-2018-023765

    DOI: 10.1136/bmjopen-2018-023765

    2018

    Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice. (Journal article)

    Reade, S., Williams, J. M., Aggio, R., Duckworth, C. A., Mahalhal, A., Hough, R., . . . Probert, C. S. (2019). Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice. FASEB JOURNAL, 33(3), 3129-3136. doi:10.1096/fj.201800076RR

    DOI: 10.1096/fj.201800076rr

    A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study (Journal article)

    Lenti, M. V., Levison, S., Eliadou, E., Willert, R., Kemp, K., Carter, A., . . . Selinger, C. P. (2018). A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study. DIGESTIVE AND LIVER DISEASE, 50(12), 1299-1304. doi:10.1016/j.dld.2018.07.007

    DOI: 10.1016/j.dld.2018.07.007

    Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis). (Journal article)

    Probert, C. S., Sebastian, S., Gaya, D. R., Hamlin, P. J., Gillespie, G., Rose, A., . . . Irving, P. M. (2018). Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis).. BMJ open gastroenterology, 5(1), e000212. doi:10.1136/bmjgast-2018-000212

    DOI: 10.1136/bmjgast-2018-000212

    Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial (Journal article)

    Bomhof, M. R., Parnell, J. A., Ramay, H. R., Crotty, P., Rioux, K. P., Probert, C. S., . . . Reimer, R. A. (2019). Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial. EUROPEAN JOURNAL OF NUTRITION, 58(4), 1735-1745. doi:10.1007/s00394-018-1721-2

    DOI: 10.1007/s00394-018-1721-2

    Oral budesonide in gastrointestinal and liver disease: A practical guide for the clinician (Journal article)

    Miehlke, S., Barreiro-de Acosta, M., Bouma, G., Carpio, D., Magro, F., Moreels, T., & Probert, C. (2018). Oral budesonide in gastrointestinal and liver disease: A practical guide for the clinician. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 33(9), 1574-1581. doi:10.1111/jgh.14151

    DOI: 10.1111/jgh.14151

    The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease (Journal article)

    Kennedy, N. A., Lamb, C. A., Berry, S. H., Walker, A. W., Mansfield, J., Parkes, M., . . . Consortium, U. K. I. B. D. G. (2018). The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease. INFLAMMATORY BOWEL DISEASES, 24(3), 583-592. doi:10.1093/ibd/izx061

    DOI: 10.1093/ibd/izx061

    A comparison of sample preparation methods for extracting volatile organic compounds (VOCs) from equine faeces using HS-SPME (Journal article)

    Hough, R., Archer, D., & Probert, C. (2018). A comparison of sample preparation methods for extracting volatile organic compounds (VOCs) from equine faeces using HS-SPME. METABOLOMICS, 14(2). doi:10.1007/s11306-017-1315-7

    DOI: 10.1007/s11306-017-1315-7

    Oral iron exacerbates colitis and influences the intestinal microbiome (Journal article)

    Mahalhal, A., Williams, J. M., Johnson, S., Ellaby, N., Duckworth, C. A., Burkitt, M. D., . . . Probert, C. S. (2018). Oral iron exacerbates colitis and influences the intestinal microbiome. PLOS ONE, 13(10). doi:10.1371/journal.pone.0202460

    DOI: 10.1371/journal.pone.0202460

    2017

    Gastrointestinal malignancies at five regional referral hospitals in Uganda (Journal article)

    Obayo, S., Lukwago, L., Orem, J., Faulx, A. L., & Probert, C. S. (2017). Gastrointestinal malignancies at five regional referral hospitals in Uganda. AFRICAN HEALTH SCIENCES, 17(4), 1051-1058. doi:10.4314/ahs.v17i4.13

    DOI: 10.4314/ahs.v17i4.13

    Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome (Journal article)

    Rossi, M., Aggio, R., Staudacher, H. M., Lomer, M. C., Lindsay, J. O., Irving, P., . . . Whelan, K. (2018). Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 16(3), 385-+. doi:10.1016/j.cgh.2017.09.055

    DOI: 10.1016/j.cgh.2017.09.055

    Effectiveness and Safety of Vedolizumab (VDZ) in IBD Patients: A Multicenter Experience of "Real World Data" From the UK (Conference Paper)

    Lenti, M. V., Levison, S., Eliadou, E., Willert, R., Kemp, K., Stansfield, C., . . . Selinger, C. (2017). Effectiveness and Safety of Vedolizumab (VDZ) in IBD Patients: A Multicenter Experience of "Real World Data" From the UK. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S381). doi:10.14309/00000434-201710001-00688

    DOI: 10.14309/00000434-201710001-00688

    VOLATILE ORGANIC COMPOUNDS PREDICT RESPONSE TO BOTH LOW FODMAP DIET AND PROBIOTICS IN IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROLLED TRIAL (Conference Paper)

    Rossi, M., Aggio, R., Staudacher, H., Lomer, M., Lindsay, J., Irving, P., . . . Whelan, K. (2017). VOLATILE ORGANIC COMPOUNDS PREDICT RESPONSE TO BOTH LOW FODMAP DIET AND PROBIOTICS IN IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROLLED TRIAL. In GUT Vol. 66 (pp. A12-A13). doi:10.1136/gutjnl-2017-314472.24

    DOI: 10.1136/gutjnl-2017-314472.24

    Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials (Journal article)

    Embleton, N. D., Berrington, J. E., Dorling, J., Ewer, A. K., Juszczak, E., Kirby, J. A., . . . Cummings, S. P. (2017). Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials. FRONTIERS IN NUTRITION, 4. doi:10.3389/fnut.2017.00014

    DOI: 10.3389/fnut.2017.00014

    A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying (Journal article)

    Reid, V. L., McDonald, R., Nwosu, A. C., Mason, S. R., Probert, C., Ellershaw, J. E., & Coyle, S. (2017). A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying. PLOS ONE, 12(4). doi:10.1371/journal.pone.0175123

    DOI: 10.1371/journal.pone.0175123

    A systematically structured review on biomarkers of dying in cancer patients at the end of life; an exploration of potential mechanisms for the biology of dying (Conference Paper)

    Reid, V., McDonald, R., Nwosu, A. C., Mason, S., Probert, C., Ellershaw, J., & Coyle, S. (2017). A systematically structured review on biomarkers of dying in cancer patients at the end of life; an exploration of potential mechanisms for the biology of dying. In BMJ Supportive and Palliative Care Vol. Volume 7. Belfast Waterfront: BMJ Publishing Group.

    Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury (Journal article)

    Carr, D. F., Ayehunie, S., Davies, A., Duckworth, C. A., French, S., Hall, N., . . . Pirmohamed, M. (2017). Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury. PHARMACOLOGY & THERAPEUTICS, 172, 181-194. doi:10.1016/j.pharmthera.2017.01.002

    DOI: 10.1016/j.pharmthera.2017.01.002

    VOLATILE ORGANIC COMPOUNDS PREDICT RESPONSE TO BOTH LOW FODMAP DIET AND PROBIOTICS IN IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROLLED TRIAL (Conference Paper)

    Rossi, M., Aggio, R., Staudacher, H., Lomer, M., Lindsay, J. O., Irving, P. M., . . . Whelan, K. (2017). VOLATILE ORGANIC COMPOUNDS PREDICT RESPONSE TO BOTH LOW FODMAP DIET AND PROBIOTICS IN IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROLLED TRIAL. In GASTROENTEROLOGY Vol. 152 (pp. S713-S714). doi:10.1016/S0016-5085(17)32486-1

    DOI: 10.1016/S0016-5085(17)32486-1

    The use of randomisation-based efficacy estimators in non-inferiority trials (Journal article)

    Gillespie, D., Farewell, D., Barrett-Lee, P., Casbard, A., Hawthorne, A. B., Hurt, C., . . . Hood, K. (2017). The use of randomisation-based efficacy estimators in non-inferiority trials. TRIALS, 18. doi:10.1186/s13063-017-1837-3

    DOI: 10.1186/s13063-017-1837-3

    Dual-focus Magnification, High-Definition Endoscopy Improves Pathology Detection in Direct-to-Test Diagnostic Upper Gastrointestinal Endoscopy (Journal article)

    Bond, A., Burkitt, M. D., Cox, T., Smart, H. L., Probert, C., Haslam, N., & Sarkar, S. (2017). Dual-focus Magnification, High-Definition Endoscopy Improves Pathology Detection in Direct-to-Test Diagnostic Upper Gastrointestinal Endoscopy. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 26(1), 19-24. doi:10.15403/jgld.2014.1121.261.gen

    DOI: 10.15403/jgld.2014.1121.261.gen

    Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis (Journal article)

    Aggio, R. B. M., White, P., Jayasena, H., Costello, B. D. L., Ratcliffe, N. M., & Probert, C. S. J. (2017). Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 45(1), 82-90. doi:10.1111/apt.13822

    DOI: 10.1111/apt.13822

    2016

    Giardiasis. (Journal article)

    Minetti, C., Chalmers, R. M., Beeching, N. J., Probert, C., & Lamden, K. (2016). CLINICAL UPDATES Giardiasis. BMJ-BRITISH MEDICAL JOURNAL, 355. doi:10.1136/bmj.i5369

    DOI: 10.1136/bmj.i5369

    Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use (Journal article)

    Subramanian, S., Asher, R., Weston, W., Rimmer, M., McConville, A., Malin, A., . . . Rhodes, J. M. (2016). Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use. INFLAMMATORY BOWEL DISEASES, 22(8), 1902-1907. doi:10.1097/MIB.0000000000000803

    DOI: 10.1097/MIB.0000000000000803

    New-Generation High-Definition Colonoscopes Increase Adenoma Detection when Screening a Moderate-Risk Population for Colorectal Cancer (Journal article)

    Bond, A., O'Toole, P., Fisher, G., Subramanian, S., Haslam, N., Probert, C., . . . Sarkar, S. (2017). New-Generation High-Definition Colonoscopes Increase Adenoma Detection when Screening a Moderate-Risk Population for Colorectal Cancer. CLINICAL COLORECTAL CANCER, 16(1), 44-50. doi:10.1016/j.clcc.2016.07.006

    DOI: 10.1016/j.clcc.2016.07.006

    Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease (Journal article)

    Reid, D. T., McDonald, B., Khalid, T., Vo, T., Schenck, L. P., Surette, M. G., . . . Eksteen, B. (2016). Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1862(7), 1337-1344. doi:10.1016/j.bbadis.2016.04.005

    DOI: 10.1016/j.bbadis.2016.04.005

    INFLUENCE OF IRON SUPPLEMENTATION ON THE NATURAL HISTORY OF COLITIS (Conference Paper)

    Mahalhal, A., Campbell, B. J., Pritchard, D. M., & Probert, C. S. (2016). INFLUENCE OF IRON SUPPLEMENTATION ON THE NATURAL HISTORY OF COLITIS. In GUT Vol. 65 (pp. A244). doi:10.1136/gutjnl-2016-312388.457

    DOI: 10.1136/gutjnl-2016-312388.457

    Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis (Journal article)

    Merga, Y. J., O Hara, A., Burkitt, M. D., Duckworth, C. A., Probert, C. S., Campbell, B. J., & Pritchard, D. M. (2016). Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis. American Journal of Physiology - Gastrointestinal and Liver Physiology, 310(11), G1081-G1090. doi:10.1152/ajpgi.00026.2016

    DOI: 10.1152/ajpgi.00026.2016

    Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors' reply (Other)

    Ahmed, I., Greenwood, R., Costello, B., Ratcliffe, N., & Probert, C. (2016). Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors' reply. In ALIMENTARY PHARMACOLOGY & THERAPEUTICS (Vol. 43, Iss. 11, pp. 1241-1242). doi:10.1111/apt.13617

    DOI: 10.1111/apt.13617

    Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort (Journal article)

    Bond, A. D., Burkitt, M. D., Sawbridge, D., Corfe, B. M., & Probert, C. S. (2016). Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 25(1), 71-77. Retrieved from http://gateway.webofknowledge.com/

    Efficacy and safety of golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study (Journal article)

    Probert, C., Gaya, D. R., Hamlin, P. J., Irving, P., Sebastian, S., Gillespie, G., . . . Wheeler, C. (2016). Efficacy and safety of golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study. JOURNAL OF CROHNS & COLITIS, 10, S57-S58. Retrieved from http://gateway.webofknowledge.com/

    Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease (Journal article)

    Ahmed, I., Greenwood, R., Costello, B., Ratcliffe, N., & Probert, C. S. (2016). Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 43(5), 596-611. doi:10.1111/apt.13522

    DOI: 10.1111/apt.13522

    Patient-reported quality of life during golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study (Conference Paper)

    Irving, P., Probert, C., Gaya, D. R., Hamlin, P. J., Sebastian, S., Gillespie, G., . . . Wheeler, C. (2016). Patient-reported quality of life during golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study. In JOURNAL OF CROHNS & COLITIS Vol. 10 (pp. S250-S251). Retrieved from http://gateway.webofknowledge.com/

    Collecting biological material from palliative care patients in the last weeks of life: a feasibility study (Journal article)

    Coyle, S., Scott, A., Nwosu, A. C., Latten, R., Wilson, J., Mayland, C. R., . . . Ellershaw, J. (2016). Collecting biological material from palliative care patients in the last weeks of life: a feasibility study. BMJ OPEN, 6(11). doi:10.1136/bmjopen-2016-011763

    DOI: 10.1136/bmjopen-2016-011763

    Freeze-drying: an alternative method for the analysis of volatile organic compounds in the headspace of urine samples using solid phase micro-extraction coupled to gas chromatography - mass spectrometry (Journal article)

    Aggio, R. B. M., Mayor, A., Coyle, S., Reade, S., Khalid, T., Ratcliffe, N. M., & Probert, C. S. J. (2016). Freeze-drying: an alternative method for the analysis of volatile organic compounds in the headspace of urine samples using solid phase micro-extraction coupled to gas chromatography - mass spectrometry. CHEMISTRY CENTRAL JOURNAL, 10. doi:10.1186/s13065-016-0155-2

    DOI: 10.1186/s13065-016-0155-2

    The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies (Journal article)

    Aggio, R. B. M., Costello, B. D. L., White, P., Khalid, T., Ratcliffe, N. M., Persad, R., & Probert, C. S. J. (2016). The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies. JOURNAL OF BREATH RESEARCH, 10(1). doi:10.1088/1752-7155/10/1/017106

    DOI: 10.1088/1752-7155/10/1/017106

    2015

    The role of budesonide in the management of Crohn's disease (Journal article)

    Boal, A., & Probert, C. (2015). The role of budesonide in the management of Crohn's disease. Gastrointestinal Nursing, 13(10), 26-33. doi:10.12968/gasn.2015.13.10.26

    DOI: 10.12968/gasn.2015.13.10.26

    The use of randomisation-based efficacy estimators in non-inferiority trials (Conference Paper)

    Gillespie, D., Hood, K., Farewell, D., Hawthorne, A., Probert, C., Stenson, R., . . . Murray, N. (2015). The use of randomisation-based efficacy estimators in non-inferiority trials. In TRIALS Vol. 16. doi:10.1186/1745-6215-16-S2-P129

    DOI: 10.1186/1745-6215-16-S2-P129

    Biosimilars: what's around the corner? (Journal article)

    Russell, R. K., Irving, P., & Probert, C. (2015). Biosimilars: what's around the corner?. Frontline gastroenterology, 6(4), 262-263. doi:10.1136/flgastro-2015-100587

    DOI: 10.1136/flgastro-2015-100587

    Managing acute severe ulcerative colitis in the hosptialised setting. (Journal article)

    McClements, D., & Probert, C. (2015). Managing acute severe ulcerative colitis in the hosptialised setting.. Frontline gastroenterology, 6(4), 241-245. doi:10.1136/flgastro-2014-100459

    DOI: 10.1136/flgastro-2014-100459

    Investigation of Volatile Organic Compounds Emitted from Faeces for the Diagnosis of Giardiasis (Journal article)

    Bond, A., Vernon, A., Reade, S., Mayor, A., Minetti, C., Wastling, J., . . . Probert, C. (2015). Investigation of Volatile Organic Compounds Emitted from Faeces for the Diagnosis of Giardiasis. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 24(3), 281-286. Retrieved from http://gateway.webofknowledge.com/

    Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease (Journal article)

    Poon, S. S., Asher, R., Jackson, R., Kneebone, A., Collins, P., Probert, C., . . . Subramanian, S. (2015). Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease. JOURNAL OF CROHNS & COLITIS, 9(8), 640-646. doi:10.1093/ecco-jcc/jjv084

    DOI: 10.1093/ecco-jcc/jjv084

    CONTRACEPTIVE PILL AND B12: LOW YIELD FROM INVESTIGATING LOW SERUM B12 IN WOMEN TAKING THE OCP (Conference Paper)

    Clark, K., Chinnappan, L., Reilly, I., & Probert, C. (2015). CONTRACEPTIVE PILL AND B12: LOW YIELD FROM INVESTIGATING LOW SERUM B12 IN WOMEN TAKING THE OCP. In GUT Vol. 64 (pp. A520). doi:10.1136/gutjnl-2015-309861.1137

    DOI: 10.1136/gutjnl-2015-309861.1137

    CORRELATION OF A PATIENT REPORTED SINGLE ITEM GLOBAL DISEASE RATING SCALE TO CLINICAL AND BIOLOGICAL MARKERS OF DISEASE ACTIVITY (Conference Paper)

    Rimmer, M., Asher, R., Jackson, R., Race, G., Collins, P., Dibb, M., . . . Subramanian, S. (2015). CORRELATION OF A PATIENT REPORTED SINGLE ITEM GLOBAL DISEASE RATING SCALE TO CLINICAL AND BIOLOGICAL MARKERS OF DISEASE ACTIVITY. In GUT Vol. 64 (pp. A241-A242). doi:10.1136/gutjnl-2015-309861.517

    DOI: 10.1136/gutjnl-2015-309861.517

    GAS CHROMATOGRAPHY SENSOR PLATFORM FOR DIAGNOSING INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME USING FAECAL SAMPLES (Conference Paper)

    Aggio, R., White, P., Costello, B. D. L., Ratcliffe, N., & Probert, C. (2015). GAS CHROMATOGRAPHY SENSOR PLATFORM FOR DIAGNOSING INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME USING FAECAL SAMPLES. In GUT Vol. 64 (pp. A53-A54). doi:10.1136/gutjnl-2015-309861.107

    DOI: 10.1136/gutjnl-2015-309861.107

    HYPERVIRULENT CLOSTRIDIUM DIFFICILE HAS A UNIQUE ODOUR PROFILE (Conference Paper)

    Reade, S., Simpson, H., Aggio, R. B. M., & Probert, C. S. J. (2015). HYPERVIRULENT CLOSTRIDIUM DIFFICILE HAS A UNIQUE ODOUR PROFILE. In GUT Vol. 64 (pp. A158). doi:10.1136/gutjnl-2015-309861.332

    DOI: 10.1136/gutjnl-2015-309861.332

    INVESTIGATION OF FAECAL VOLATILE ORGANIC COMPOUNDS AS BIOMARKERS FOR THE DIAGNOSIS OF NECROTISING ENTERCOLITIS (Thesis / Dissertation)

    Mayor, A., Ellaby, N., Reade, S., Aggio, R., Greenwood, R., Jackson, R., . . . Ewer, A. K. (2015). INVESTIGATION OF FAECAL VOLATILE ORGANIC COMPOUNDS AS BIOMARKERS FOR THE DIAGNOSIS OF NECROTISING ENTERCOLITIS. Retrieved from http://gateway.webofknowledge.com/

    DOI: 10.1136/gutjnl-2015-309861.30

    INVESTIGATION OF VOLATILE ORGANIC COMPOUNDS EMITTED FROM FAECES FOR THE DIAGNOSIS OF GIARDIASIS (Conference Paper)

    Bond, A., Vernon, A., Reade, S., Mayor, A., Wastling, J., Minetti, C., . . . Probert, C. (2015). INVESTIGATION OF VOLATILE ORGANIC COMPOUNDS EMITTED FROM FAECES FOR THE DIAGNOSIS OF GIARDIASIS. In GUT Vol. 64 (pp. A288). doi:10.1136/gutjnl-2015-309861.620

    DOI: 10.1136/gutjnl-2015-309861.620

    PATIENTS RECEIVING ANTI-TNF AGENTS FOR INFLAMMATORY BOWEL DISEASE: EXPOSURE TO DIAGNOSTIC IONISING RADIATION AND TRENDS IN IMAGING MODALITIES (Conference Paper)

    Meredith, S., Dibb, M., Ellis, T., Gordon, M., Probert, C., Subramanian, S., & Collins, P. (2015). PATIENTS RECEIVING ANTI-TNF AGENTS FOR INFLAMMATORY BOWEL DISEASE: EXPOSURE TO DIAGNOSTIC IONISING RADIATION AND TRENDS IN IMAGING MODALITIES. In GUT Vol. 64 (pp. A437). doi:10.1136/gutjnl-2015-309861.958

    DOI: 10.1136/gutjnl-2015-309861.958

    QUALITY OF CARE IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: HOW DO PATIENTS RATE THEIR QUALITY OF CARE? (Conference Paper)

    Ding, W. Y., Baigent, A., Bunger, K., Dibb, M., Ellis, T., Gordon, M., . . . Collins, P. (2015). QUALITY OF CARE IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: HOW DO PATIENTS RATE THEIR QUALITY OF CARE?. In GUT Vol. 64 (pp. A209-A210). doi:10.1136/gutjnl-2015-309861.449

    DOI: 10.1136/gutjnl-2015-309861.449

    RESILIENCE AND PROTECTION AGAINST THE DOSE-RELATED TOXICITY OF HYDROGEN SULPHIDE (Conference Paper)

    Sawbridge, D., Wilson, J., & Probert, C. (2015). RESILIENCE AND PROTECTION AGAINST THE DOSE-RELATED TOXICITY OF HYDROGEN SULPHIDE. In GUT Vol. 64 (pp. A364). doi:10.1136/gutjnl-2015-309861.796

    DOI: 10.1136/gutjnl-2015-309861.796

    THE INFLUENCE OF IRON SUPPLEMENTATION ON THE SEVERITY OF A MURINE MODEL OF COLITIS (Conference Paper)

    Mahalhal, A., Reade, S., Campbell, B., Pritchard, D. M., & Probert, C. (2015). THE INFLUENCE OF IRON SUPPLEMENTATION ON THE SEVERITY OF A MURINE MODEL OF COLITIS. In GUT Vol. 64 (pp. A92). doi:10.1136/gutjnl-2015-309861.187

    DOI: 10.1136/gutjnl-2015-309861.187

    URINARY VOLATILE ORGANIC COMPOUNDS AS A BIOMARKER FOR HEPATOCELLULAR CARCINOMA (HCC) (Conference Paper)

    Bond, A., Aggio, R., Johnson, P., Berhane, S., & Probert, C. (2015). URINARY VOLATILE ORGANIC COMPOUNDS AS A BIOMARKER FOR HEPATOCELLULAR CARCINOMA (HCC). In GUT Vol. 64 (pp. A462). doi:10.1136/gutjnl-2015-309861.1011

    DOI: 10.1136/gutjnl-2015-309861.1011

    VOLATILE ORGANIC COMPOUND (VOC) PROFILES AS INDICATORS OF EARLY LESIONS IN MURINE COLON CARCINOGENESIS (Conference Paper)

    Reade, S., Williams, J. M., Pritchard, D. M., & Probert, C. S. J. (2015). VOLATILE ORGANIC COMPOUND (VOC) PROFILES AS INDICATORS OF EARLY LESIONS IN MURINE COLON CARCINOGENESIS. In GUT Vol. 64 (pp. A374-A375). doi:10.1136/gutjnl-2015-309861.819

    DOI: 10.1136/gutjnl-2015-309861.819

    Resilience and protection against the dose-related toxicity of hydrogen sulphide (Conference Paper)

    Sawbridge, D., Wilson, J., & Probert, C. (2015). Resilience and protection against the dose-related toxicity of hydrogen sulphide. In NITRIC OXIDE-BIOLOGY AND CHEMISTRY Vol. 47 (pp. S17). doi:10.1016/j.niox.2015.02.041

    DOI: 10.1016/j.niox.2015.02.041

    Review article: cytomegalovirus and inflammatory bowel disease (Journal article)

    Sager, K., Alam, S., Bond, A., Chinnappan, L., & Probert, C. S. (2015). Review article: cytomegalovirus and inflammatory bowel disease. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 41(8), 725-733. doi:10.1111/apt.13124

    DOI: 10.1111/apt.13124

    The Impact of NOD2 Variants on Gut Microbiota in Crohn's Disease and Healthy Controls (Conference Paper)

    Kennedy, N. A., Walker, A. W., Berry, S. H., Lamb, C. A., Lewis, S., Mansfield, J. C., . . . Consortium, U. K. I. B. D. G. (2015). The Impact of NOD2 Variants on Gut Microbiota in Crohn's Disease and Healthy Controls. In GASTROENTEROLOGY Vol. 148 (pp. S718). Retrieved from http://gateway.webofknowledge.com/

    Diverticular disease (Journal article)

    Gaglia, A., & Probert, C. S. (2015). Diverticular disease. Medicine, 43(6), 320-323. doi:10.1016/j.mpmed.2015.03.002

    DOI: 10.1016/j.mpmed.2015.03.002

    Upper gastrointestinal diseases in patients for endoscopy in South-Western Uganda (Journal article)

    Obayo, S., Muzoora, C., Ocama, P., Cooney, M. M., Wilson, T., & Probert, C. S. (2015). Upper gastrointestinal diseases in patients for endoscopy in South-Western Uganda. AFRICAN HEALTH SCIENCES, 15(3), 959-966. doi:10.4314/ahs.v15i3.33

    DOI: 10.4314/ahs.v15i3.33

    Urinary Volatile Organic Compounds for the Detection of Prostate Cancer (Journal article)

    Khalid, T., Aggio, R., White, P., Costello, B. D. L., Persad, R., Al-Kateb, H., . . . Ratcliffe, N. (2015). Urinary Volatile Organic Compounds for the Detection of Prostate Cancer. PLOS ONE, 10(11). doi:10.1371/journal.pone.0143283

    DOI: 10.1371/journal.pone.0143283

    2014

    Identifying and quantifying metabolites by scoring peaks of GC-MS data (Journal article)

    Aggio, R. B. M., Mayor, A., Reade, S., Probert, C. S. J., & Ruggiero, K. (2014). Identifying and quantifying metabolites by scoring peaks of GC-MS data. BMC BIOINFORMATICS, 15. doi:10.1186/s12859-014-0374-2

    DOI: 10.1186/s12859-014-0374-2

    Effect of "acid protect" supplementation on the volatile faecal metabolome of thoroughbred racehorses (Conference Paper)

    Larkins, N., Proudman, C. J., Travers, J., Probert, C. J., & Koare, K. (2014). Effect of "acid protect" supplementation on the volatile faecal metabolome of thoroughbred racehorses. In IMMUNOLOGY Vol. 143 (pp. 20). Retrieved from http://gateway.webofknowledge.com/

    Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease? (Journal article)

    Probert, C. S. J., Reade, S., & Ahmed, I. (2014). Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease?. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 10(9), 1129-1131. doi:10.1586/1744666X.2014.943664

    DOI: 10.1586/1744666X.2014.943664

    A METABOLOMIC PROFILING STUDY OF A CHEMICALLY-INDUCED MOUSE MODEL OF INTESTINAL INFLAMMATION (Conference Paper)

    Reade, S., Duckworth, C. A., Khalid, T., Mayor, A., Aggio, R., Pritchard, D. M., & Probert, C. S. (2014). A METABOLOMIC PROFILING STUDY OF A CHEMICALLY-INDUCED MOUSE MODEL OF INTESTINAL INFLAMMATION. In GUT Vol. 63 (pp. A172). doi:10.1136/gutjnl-2014-307263.369

    DOI: 10.1136/gutjnl-2014-307263.369

    INCREASING WEIGHT AND BODY MASS INDEX ADVERSELY AFFECT THIOGUANINE NUCLEOTIDE LEVELS IN INFLAMMATORY BOWEL DISEASE (Conference Paper)

    Subramanian, S., Poon, S., Kneebone, A., Asher, R., Jackson, R., Gregg, B., . . . Dibb, M. (2014). INCREASING WEIGHT AND BODY MASS INDEX ADVERSELY AFFECT THIOGUANINE NUCLEOTIDE LEVELS IN INFLAMMATORY BOWEL DISEASE. In GUT Vol. 63 (pp. A168). doi:10.1136/gutjnl-2014-307263.360

    DOI: 10.1136/gutjnl-2014-307263.360

    MEAN CORPUSCULAR VOLUME BUT NOT LYMPHOCYTE COUNT IS A PREDICTOR OF THIOPURINE DOSE ADEQUACY AND TOXICITY (Conference Paper)

    Kneebone, A., Poon, S. S., Asher, R., Jackson, R., Gregg, B., Kerr, S., . . . Dibb, M. (2014). MEAN CORPUSCULAR VOLUME BUT NOT LYMPHOCYTE COUNT IS A PREDICTOR OF THIOPURINE DOSE ADEQUACY AND TOXICITY. In GUT Vol. 63 (pp. A157-A158). doi:10.1136/gutjnl-2014-307263.338

    DOI: 10.1136/gutjnl-2014-307263.338

    PAEDIATRIC FAECAL VOC ANALYSIS: METHOD OPTIMISATION (Conference Paper)

    Mayor, A., Reade, S., Aggio, R., Khalid, T., & Probert, C. (2014). PAEDIATRIC FAECAL VOC ANALYSIS: METHOD OPTIMISATION. In GUT Vol. 63 (pp. A218). doi:10.1136/gutjnl-2014-307263.469

    DOI: 10.1136/gutjnl-2014-307263.469

    Population-based Screening in Colorectal Cancer - Current Practice and Future Developments: Faecal Biomarkers Review (Journal article)

    Sawbridge, D., & Probert, C. (2014). Population-based Screening in Colorectal Cancer - Current Practice and Future Developments: Faecal Biomarkers Review. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 23(2), 195-202. Retrieved from http://gateway.webofknowledge.com/

    THE IMPACT OF NOD2 VARIANTS ON GUT MICROBIOTA IN CROHN'S DISEASE AND HEALTHY CONTROLS (Conference Paper)

    Kennedy, N. A., Walker, A. W., Berry, S. H., Lamb, C. A., Lewis, S., Mansfield, J., . . . Consortium, U. K. I. B. D. G. (2014). THE IMPACT OF NOD2 VARIANTS ON GUT MICROBIOTA IN CROHN'S DISEASE AND HEALTHY CONTROLS. In GUT Vol. 63 (pp. A159-S160). doi:10.1136/gutjnl-2014-307263.342

    DOI: 10.1136/gutjnl-2014-307263.342

    The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients (Journal article)

    Shepherd, S. F., McGuire, N. D., de Lacy Costello, B. P. J., Ewen, R. J., Jayasena, D. H., Vaughan, K., . . . Ratcliffe, N. M. (2014). The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients. JOURNAL OF BREATH RESEARCH, 8(2). doi:10.1088/1752-7155/8/2/026001

    DOI: 10.1088/1752-7155/8/2/026001

    Towards point of care testing for C. difficile infection by volatile profiling, using the combination of a short multi-capillary gas chromatography column with metal oxide sensor detection (Journal article)

    McGuire, N. D., Ewen, R. J., Costello, B. D. L., Garner, C. E., Probert, C. S. J., Vaughan, K., & Ratcliffe, N. M. (2014). Towards point of care testing for C. difficile infection by volatile profiling, using the combination of a short multi-capillary gas chromatography column with metal oxide sensor detection. MEASUREMENT SCIENCE AND TECHNOLOGY, 25(6). doi:10.1088/0957-0233/25/6/065108

    DOI: 10.1088/0957-0233/25/6/065108

    Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life (Journal article)

    Probert, C. S. J., Dignass, A. U., Lindgren, S., Pool, M. O., & Marteau, P. (2014). Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life. JOURNAL OF CROHNS & COLITIS, 8(3), 200-207. doi:10.1016/j.crohns.2013.08.007

    DOI: 10.1016/j.crohns.2013.08.007

    Early Use of Azathioprine in Crohn's Disease (Journal article)

    Hawthorne, A. B., Probert, C. S. J., & Sanderson, J. D. (2014). Early Use of Azathioprine in Crohn's Disease. GASTROENTEROLOGY, 146(3), 866-+. doi:10.1053/j.gastro.2013.10.072

    DOI: 10.1053/j.gastro.2013.10.072

    The Liver Breath! Breath Volatile Organic Compounds for the Diagnosis of Liver Disease (Journal article)

    Khalid, T., Richardson, P., & Probert, C. S. (2014). The Liver Breath! Breath Volatile Organic Compounds for the Diagnosis of Liver Disease. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(3), 524-526. doi:10.1016/j.cgh.2013.10.032

    DOI: 10.1016/j.cgh.2013.10.032

    A rare cause of weight loss (Journal article)

    Flanagan, P. K., Coupland, S. E., Arumainathan, A., & Probert, C. S. J. (2014). A rare cause of weight loss. GUT, 63(6), 1024-1025. doi:10.1136/gutjnl-2013-306299

    DOI: 10.1136/gutjnl-2013-306299

    Electronic Monitoring of Medication Adherence in a 1-year Clinical Study of 2 Dosing Regimens of Mesalazine for Adults in Remission with Ulcerative Colitis (Journal article)

    Gillespie, D., Hood, K., Farewell, D., Stenson, R., Probert, C., & Hawthorne, A. B. (2014). Electronic Monitoring of Medication Adherence in a 1-year Clinical Study of 2 Dosing Regimens of Mesalazine for Adults in Remission with Ulcerative Colitis. INFLAMMATORY BOWEL DISEASES, 20(1), 82-91. doi:10.1097/01.MIB.0000437500.60546.2a

    DOI: 10.1097/01.MIB.0000437500.60546.2a

    Future Methods for the Diagnosis of Inflammatory Bowel Disease (Journal article)

    Aggio, R., & Probert, C. (2014). Future Methods for the Diagnosis of Inflammatory Bowel Disease. DIGESTIVE DISEASES, 32(4), 463-467. doi:10.1159/000358153

    DOI: 10.1159/000358153

    PWE-109 A Metabolomic Profiling Study Of A Chemically-induced Mouse Model Of Intestinal Inflammation (Conference Paper)

    Reade, S., Duckworth, C. A., Khalid, T., Mayor, A., Aggio, R., Pritchard, D. M., & Probert, C. S. (2014). PWE-109 A Metabolomic Profiling Study Of A Chemically-induced Mouse Model Of Intestinal Inflammation. In Gut Vol. 63 (pp. A172).

    2013

    An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome (Journal article)

    Ahmed, I., Greenwood, R., Costello, B. D. L., Ratcliffe, N. M., & Probert, C. S. (n.d.). An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome. PLoS ONE, 8(3), e58204. doi:10.1371/journal.pone.0058204

    DOI: 10.1371/journal.pone.0058204

    Best of Five MCQs for the Gastroenterology SCE (Book)

    Rutter, C., Griffiths, L., Mehta, T., & Probert, C. (Eds.) (2013). Best of Five MCQs for the Gastroenterology SCE. Oxford: Oxford University Press.

    Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: a pilot study (Journal article)

    Khalid, T. Y., Costello, B. D. L., Ewen, R., White, P., Stevens, S., Gordon, F., . . . Probert, C. S. (2013). Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: a pilot study. Metabolomics, 9(5), 938-948. doi:10.1007/s11306-013-0510-4

    DOI: 10.1007/s11306-013-0510-4

    Comparison of a Frozen Human Foreskin Fibroblast Cell Assay to an Enzyme Immunoassay and Toxigenic Culture for the Detection of Toxigenic Clostridium difficile (Journal article)

    Strachan, A. J., Evans, N. E., & Probert, C. J. (2013). Comparison of a Frozen Human Foreskin Fibroblast Cell Assay to an Enzyme Immunoassay and Toxigenic Culture for the Detection of Toxigenic Clostridium difficile. Diagnostic Microbiology & Infectious Disease, 75(1), 42-45. doi:10.1016/j.diagmicrobio.2012.09.0

    DOI: 10.1016/j.diagmicrobio.2012.09.0

    IL-13 Promotes Collagen Accumulation in Crohn’s Disease Fibrosis by Down-Regulation of Fibroblast MMP Synthesis: A Role for Innate Lymphoid Cells? (Journal article)

    Bailey, J. R., Bland, P. W., Tarlton, J. F., Peters, I., Moorghen, M., Sylvester, P. A., . . . Whiting, C. V. (n.d.). IL-13 Promotes Collagen Accumulation in Crohn’s Disease Fibrosis by Down-Regulation of Fibroblast MMP Synthesis: A Role for Innate Lymphoid Cells?. PLoS ONE, 7(12), e52332. doi:10.1371/journal.pone.0052332

    DOI: 10.1371/journal.pone.0052332

    Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis (Journal article)

    Flourié, B., Hagège, H., Tucat, G., Maetz, D., Hébuterne, X., Kuyvenhoven, J. P., . . . Aoucheta, D. (2013). Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis. Alimentary Pharmacology & Therapeutics, 37(8), 767-775. doi:10.1111/apt.12266

    DOI: 10.1111/apt.12266

    2012

    'One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis' (Journal article)

    Hawthorne, A. B., Stenson, R., Gillespie, D., Swarbrick, E. T., Dhar, A., Kapur, K. C., . . . Probert, C. S. J. (2012). 'One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis'. Inflammatory Bowel Disease, 18(10), 1885-1893.

    Basiliximab Does Not Increase Efficacy of Corticosteroids in Patients With Steroid-Refractory Ulcerative Colitis (Journal article)

    Sands, B. E., Sandborn, W. J., Creed, T. J., Dayan, C. M., Dhanda, A. D., Van Assche, G. A., . . . Probert, C. S. (2012). Basiliximab Does Not Increase Efficacy of Corticosteroids in Patients With Steroid-Refractory Ulcerative Colitis. Gastroenterology, 143(2), 356-364.e1. doi:10.1053/j.gastro.2012.04.043

    DOI: 10.1053/j.gastro.2012.04.043

    Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials? (Journal article)

    Dhanda, A. D., Creed, T. J., Greenwood, R., Sands, B. E., & Probert, C. S. (2012). Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?. Inflammatory Bowel Diseases, 18(11), 2056-2062. doi:10.1002/ibd.22879

    DOI: 10.1002/ibd.22879

    Diagnosis of bladder cancer from urinary volatile biomarker (Journal article)

    Khalid, T. Y., Ratcliffe, N. M., & Probert, C. S. (2012). Diagnosis of bladder cancer from urinary volatile biomarker. Cancer.

    Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease (Journal article)

    Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., . . . Rioux, K. P. (2013). Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology, 11(7), 868-875.e3. doi:10.1016/j.cgh.2013.02.015

    DOI: 10.1016/j.cgh.2013.02.015

    Impact of Coeliac Disease on the Partner’s diet- No Altruism (Journal article)

    Hettiarachchi, I. T., & Rowbotham, D. (2012). Impact of Coeliac Disease on the Partner’s diet- No Altruism. Journal of Nutrition & Food Sciences, 02(03). doi:10.4172/2155-9600.1000135

    DOI: 10.4172/2155-9600.1000135

    Prevention of postoperative recurrence of Crohn's disease (Chapter)

    Ayres, L. O. R., & Probert, C. S. J. (2012). Prevention of postoperative recurrence of Crohn's disease. In A. Hart, & S. W. Ng (Eds.), Inflammatory Bowel Disease: An Evidence-based Practical Guide (pp. 119-132). Tarxien: Gutenberg Presss Ltd.

    2011

    'The Molecular Biology of Inflammatory Bowel Diseases' (Journal article)

    Corfield, A. P., Wallace, H. M., & Probert, C. S. J. (2011). 'The Molecular Biology of Inflammatory Bowel Diseases'. Biochemical Society Transactions, 39(4), 1057-1060.

    'Which EIMs respond to biologics?' (Chapter)

    Metha, T., & Probert, C. (2011). 'Which EIMs respond to biologics?'. In C. Siegel, P. Irving, D. Rampton, & F. Shanahan (Eds.), Clinical Dilemmas in Inflammatory Bowel Disease - New Challenges.. Oxford: Blackwell.

    Can 11β-Hydroxysteroid Dehydrogenase Activity Predict the Sensitivity of Bone to Therapeutic Glucocorticoids in Inflammatory Bowel Disease? (Journal article)

    Cooper, M. S., Kriel, H., Sayers, A., Fraser, W. D., Williams, A. M., Stewart, P. M., . . . Tobias, J. H. (2011). Can 11β-Hydroxysteroid Dehydrogenase Activity Predict the Sensitivity of Bone to Therapeutic Glucocorticoids in Inflammatory Bowel Disease?. Calcified Tissue International, 89(3), 246-251. doi:10.1007/s00223-011-9512-2

    DOI: 10.1007/s00223-011-9512-2

    Identification and Characterisation of an Iron-Responsive Candidate Probiotic (Journal article)

    Bailey, J. R., Probert, C. S. J., & Cogan, T. A. (n.d.). Identification and Characterisation of an Iron-Responsive Candidate Probiotic. PLoS ONE, 6(10), e26507. doi:10.1371/journal.pone.0026507

    DOI: 10.1371/journal.pone.0026507

    Role of faecal gas analysis for the diagnosis of IBD (Journal article)

    Probert, C. S. J. (2011). Role of faecal gas analysis for the diagnosis of IBD. Biochemical Society Transactions, 39(4), 1079-1080. doi:10.1042/bst0391079

    DOI: 10.1042/bst0391079

    2010

    'A costly diagnostic failure' (Journal article)

    Assadsangabi, A., Probert, C., & Pope, I. (2010). 'A costly diagnostic failure'. J Fam Pract,, 59(11), 624-626.

    'Mortality in ulcerative colitis—what should we tell our patients? Three year mortality following admission for the treatment of ulcerative colitis: a 6 year retrospective case review' (Journal article)

    Falvey, J., Greenwood, R., Creed, T. J., Smithson, J., Sylvester, P., Fraser, A., & Probert, C. S. (2010). 'Mortality in ulcerative colitis—what should we tell our patients? Three year mortality following admission for the treatment of ulcerative colitis: a 6 year retrospective case review'. Frontline Gastroenterology, 1, 35-41.

    'Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease.' (Journal article)

    Kriel, M. H., Tobias, J. H., Creed, T. J., Lockett, M., Linehan, J., Bell, A., . . . Probert, C. S. J. (2010). 'Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease.'. Unknown Journal, 21, 507-513.

    2009

    'Analysis of faecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study.' (Journal article)

    Garner, C. E., Ewer, A., Elasouad, K., Power, F., Greenwood, R., Ratcliffe, N. M., . . . Probert, C. S. (2009). 'Analysis of faecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study.'. Journal of Pediatric Gastroenterology and Nutrition, 49, 559-565.

    2007

    'The effect of weaning on the clonality of alpha-beta T cell receptor T cells in the intestine of GF and SPF mice' (Journal article)

    Probert, C. S. J., Williams, A. M., Stepankova, R., Tlaskalova-Hogenova, H., Phillips, A., & Bland, P. W. (2007). 'The effect of weaning on the clonality of alpha-beta T cell receptor T cells in the intestine of GF and SPF mice'. Developmental & Comparative Immunology, 31, 606-617.

    'Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease' (Journal article)

    Garner, C. E., Smith, S., de Lacy Costello, B., White, P., Spencer, R., Probert, C. S. J., & Ratcliffe, N. M. (2007). 'Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease'. FASEBJ, 21, 1675-1688.

    2006

    ' Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse' (Journal article)

    Williams, A., Probert, C., Stepankova, R., Tlaskalova-Hogenova, H., Phillips, A., & Bland, P. (2006). ' Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse'. Immunology, 119, 470-478.

    'Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial.' (Journal article)

    Brooklyn, T. N., Dunnill, M. G. S., Shetty, A., Bowden, J. J., Williams, J. D. L., Griffiths, C. E. M., . . . Probert, C. S. (2006). 'Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial.'. Gut, 55, 505-509.